Both in Biotechnology
Kyverna Therapeutics vs Fennec Pharmaceuticals
Over the past year KYTX returned −17.6% and FENC returned +26.0%; their daily moves had a correlation of 0.29.
KYTX −17.6% FENC +26.0%Growth of $1, one year, split-adjusted
| Metric | KYTX | FENC |
|---|---|---|
| Price | $5.67 | $10.24 |
| Market cap | $350.7M | $359.1M |
| Today | −3.08% | −6.48% |
| 1 month | −13.0% | −0.9% |
| 6 months | −36.1% | +56.6% |
| Year to date | −39.7% | +33.0% |
| 1 year | −20.9% | +20.9% |
| Revenue growth (YoY) | — | +85.2% |
| Gross margin | — | 96.0% |
| Net margin | — | 11.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.1× |
| Net cash | $174.4M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 57.5% |
| Short % of float | 26.6% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).